Which COVID-19 Treatments Offer the Most Promise?

According to experts, antibody-based treatments, among the older drugs or new approaches tried so far, are the most promising treatment for COVID-19. One of the treatments reportedly given early to United States President Donald Trump, who recently received treatment for COVID-19, is an antibody treatment still being developed by Regeneron.
Dr. Luke O'Neill, Chair of Biochemistry at Trinity College in Ireland, who gave the keynote address on COVID-19 treatments at the 2020 ESCMID Conference on Coronavirus Disease (ECCVID), says: "There is great hope in antibody treatments."
Dr. O'Neill said: "In my opinion, the approval of an antibody treatment will be a major breakthrough for people. Many companies are developing truly potent anti-spike antibodies (against the virus's spike proteins), and they are promising. Antibodies are also extremely safe; for example, they can be used prophylactically (preventively) in nursing homes or older people. With results from clinical trials to be reported in November / December, antibodies could make a major breakthrough ahead of vaccines. There are currently 44 clinical trials working on antibody treatments."
What are antibodies, and how are they produced?
An antibody is part of the body's humoral (fluid-based) defense, normally produced by plasma cells, a differentiated form of the immune system's B cells. Antibodies suppress the harmful effects of pathogens by binding to antigens (molecules specific to pathogens). The following figure shows, after a viral infection, B cell activation and antibody production.
People infected with the novel coronavirus (SARS-CoV-2) develop antibodies against the virus after COVID-19 infection. However, for many years, antibodies have also been produced in laboratories as biotechnological drugs. Many scientific studies are being conducted to investigate whether producing large quantities of antibodies in the laboratory could make it possible to treat COVID-19 or protect against coronavirus.
Cortisone and the BCG vaccine
For dexamethasone (cortisone), reductions in mortality of up to 70% among intubated patients on mechanical ventilation in intensive care are reported in studies that are available.
Another noteworthy study for COVID-19 treatment concerns the BCG vaccine, which we have used for decades to protect against the tuberculosis bacterium (TB). Regarding research on the immune memory response of the BCG vaccine, which is known to provide some protection against other respiratory viruses, Dr. O'Neill said: "There are currently 7 studies investigating the effects of BCG in coronavirus infection, and they will soon begin producing results; this will allow us to see the effects of the BCG vaccine. These studies are a bridge to the COVID-19 vaccine."
The coronavirus vaccine trial with the largest number of participants has begun
In addition, the latest phase 3 COVID-19 vaccine candidate clinical trial, recently launched by Johnson & Johnson, is the largest in medical history in terms of the number of people [60,000], so you should be hopeful. Even if SARS-CoV-2 vaccines are partially effective, they will be enormously helpful (see the vaccine race against coronavirus)
Remdesivir appears effective and safe
The final report of the multinational, placebo-controlled ACTT-1 trial confirms that remdesivir is effective in shortening recovery time from COVID-19 infection and is well tolerated.
In May 2020, remdesivir received emergency "authorization for use" for severe COVID-19 from the United States Food and Drug Administration (FDA) based on a preliminary report of this clinical trial (not approval; there is not yet an approved treatment for COVID-19). In August 2020, the FDA expanded the use of remdesivir to include all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19 infection, regardless of severity.
The volume of research already published on COVID-19 has become enormous. The latest PubMed (medical scientific research database) search surprisingly found more than 55 thousand original articles on SARS-CoV-2, a completely new virus.
This demonstrates the enormous efforts of scientists, physicians, all healthcare workers, and the pharmaceutical industry against this virus. It is a truly wonderful example of the world acting together to fight the virus.
Sources
2. John H. Beigel, et al. Remdesivir for the Treatment of Covid-19 — Final Report. NEJM 8 October 2020
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.